BackMirati Therapeutics Overview

Mirati Therapeutics Total Revenue

Revenue analysis for MRTX.

Quarterly Revenue

$16.40M
↑ 201.97% YoY

As of Sep 2023

Annual Revenue (TTM)

$38.19M
↑ 223.63% YoY

Trailing 12 months ending Sep 2023

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin